Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $64,585.09 +0.36%
Ethereum $1,912.83 +0.34%
BNB $602.53 -0.46%
Optimism $0.08 -2.15%
Arbitrum $0.08 -0.23%
Solana $76.93 +1.31%
Polygon $0.22 +2.77%
Cosmos $1.43 +0.22%
Avalanche $6.31 -0.33%

Bitcoin $64,585.09 +0.36%
Ethereum $1,912.83 +0.34%
BNB $602.53 -0.46%
Optimism $0.08 -2.15%
Arbitrum $0.08 -0.23%
Solana $76.93 +1.31%
Polygon $0.22 +2.77%
Cosmos $1.43 +0.22%
Avalanche $6.31 -0.33%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B